SS
MYGN icon

Sunbelt Securities’s Myriad Genetics MYGN Stock Holding History

Sunbelt Securities’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$801 Buy
178
+34
+24% +$177 ﹤0.01% 2156
2025
Q4 		$886 Hold
144
– – ﹤0.01% 2089
2025
Q3 		$1.04K Buy
+144
New +$855 ﹤0.01% 2036

Other funds holding MYGN

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sunbelt Securities's MYGN Position: Q1 2026 in Review

Sunbelt Securities increased its Myriad Genetics (MYGN) stake by 24% in Q1 2026, buying an estimated $177 and bringing the position to 178 shares worth $801. The position accounts for ﹤0.01% of the portfolio, ranked #2156.

Sunbelt Securities first reported a position in MYGN in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.04K in Q3 2025. 203 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.

  • Sunbelt Securities held 178 shares of Myriad Genetics worth $801 as of Q1 2026.
  • Sunbelt Securities bought 34 Myriad Genetics shares in Q1 2026, an estimated $177.
  • Myriad Genetics made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2156 holding.
  • Sunbelt Securities first reported a position in Myriad Genetics in Q3 2025 and has held it in 3 quarters since.
  • Sunbelt Securities's Myriad Genetics position peaked at $1.04K in Q3 2025.
  • 203 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.